Neuronetics, Inc.
STIM
$3.20
-$0.20-5.88%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 111.11M | 89.45M | 74.89M | 72.71M | 72.07M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 111.11M | 89.45M | 74.89M | 72.71M | 72.07M |
Cost of Revenue | 48.12M | 32.04M | 20.13M | 15.77M | 17.36M |
Gross Profit | 62.99M | 57.41M | 54.76M | 56.94M | 54.70M |
SG&A Expenses | 89.06M | 83.49M | 75.96M | 73.35M | 72.52M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 148.78M | 127.57M | 108.86M | 98.33M | 98.83M |
Operating Income | -37.67M | -38.12M | -33.97M | -25.62M | -26.76M |
Income Before Tax | -48.55M | -48.54M | -43.73M | -36.42M | -32.47M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -48.55 | -48.54 | -43.73 | -36.42 | -32.47 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -248.00K | 33.00K | 19.00K | -- | -- |
Net Income | -48.80M | -48.51M | -43.71M | -36.42M | -32.47M |
EBIT | -37.67M | -38.12M | -33.97M | -25.62M | -26.76M |
EBITDA | -35.04M | -35.84M | -32.03M | -23.63M | -24.80M |
EPS Basic | -1.15 | -1.32 | -1.38 | -1.22 | -1.10 |
Normalized Basic EPS | -0.66 | -0.77 | -0.80 | -0.63 | -0.65 |
EPS Diluted | -1.15 | -1.32 | -1.38 | -1.22 | -1.10 |
Normalized Diluted EPS | -0.66 | -0.77 | -0.80 | -0.63 | -0.65 |
Average Basic Shares Outstanding | 194.59M | 158.46M | 126.46M | 118.84M | 117.45M |
Average Diluted Shares Outstanding | 194.59M | 158.46M | 126.46M | 118.84M | 117.45M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |